在道化纳米管中进行线粒体转移 - - 这是癌症治疗的新目标
Fan Guan1, Xiaomin Wu1, Jiatong Zhou1
1NHC Key Laboratory of Carcinogenesis and Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
概括
癌细胞利用有氧糖解 (华堡效应). 这篇评论探讨了线粒体在瘤中的转移如何推动癌症的攻击性,化学抵抗和免疫逃避,提供新的治疗点.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 代谢调节 代谢调节 代谢调节 代谢调节
背景情况:
- 华堡效应描述了癌细胞对糖解的依赖,即使有氧.
- 瘤微环境中细胞之间的线粒体转移是一个新发现的现象.
- 这些转移会影响瘤的进展和治疗反应.
研究的目的:
- 审查瘤微环境中线粒体转移的机制.
- 阐明线粒体转移如何影响瘤的攻击性,化疗耐药性和免疫逃避.
- 讨论针对线粒体转移的临床意义和治疗潜力.
主要方法:
- 对癌症中线粒体转移研究的文献综述.
- 分析涉及细胞间线粒体转移的途径和机制.
- 对向线粒体转移用于癌症治疗的研究进行评估.
主要成果:
- 线粒体转移有助于瘤细胞的适应和增殖.
- 细胞间线粒体转移增强了对化疗的耐药性.
- 线粒体交换促进了瘤细胞的免疫逃避.
结论:
- 准细胞间线粒体转移是一个有希望的抗癌策略.
- 调节线粒体转移可以提高免疫治疗的疗效.
- 需要进一步的研究来将这些发现转化为临床应用.
相关概念视频
Electron Transport Chain: Complex I and II
13.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.0K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Translocation of Proteins into the Mitochondria
3.1K
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
3.1K
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K


